Vanda Pharmaceuticals Inc.（VNDA）内部人交易：高管与董事近期交易
过去 18 个月，共有 12 位内部人为 Vanda Pharmaceuticals Inc.（VNDA）报告了 30 笔 Form 4 交易（最近一笔 2026-06-08）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-08 | DUGAN RICHARD W | 董事 | 买入 | 41,600 | $0 |
| 2026-06-08 | Mitchell Stephen Ray | 董事 | 买入 | 41,600 | $0 |
| 2026-06-08 | McGuire Daniel Patrick | SVP, GC and Secretary | 买入 | 80,000 | $0 |
| 2026-06-08 | Honore Tage | 董事 | 买入 | 41,600 | $0 |
| 2026-06-08 | Chrousos Phaedra | 董事 | 买入 | 41,600 | $0 |
| 2026-06-08 | Ward Anne Sempowski | 董事 | 买入 | 41,600 | $0 |
| 2026-06-08 | Duncan Charles Cliff | 董事 | 买入 | 41,600 | $0 |
| 2026-05-20 | Mitchell Stephen Ray | 董事 | 卖出 | 25,836 | $0 |
| 2026-04-24 | Duncan Charles Cliff | 董事 | 买入 | 57,101 | $0 |
| 2026-03-04 | Moran Kevin Patrick | SVP, CFO & Treasurer | 卖出 | 42,442 | $350,995 |
| 2026-03-04 | Birznieks Gunther | SVP, Business Development | 卖出 | 42,431 | $350,904 |
| 2026-03-04 | Williams Timothy | SVP & General Counsel | 卖出 | 42,434 | $350,929 |
| 2026-03-04 | Wijkstrom Joakim | SVP, Chief Marketing Officer | 卖出 | 30,800 | $254,716 |
| 2026-03-04 | Polymeropoulos Mihael Hristos | President and CEO | 卖出 | 156,235 | $1.3M |
| 2026-02-24 | Honore Tage | 董事 | 卖出 | 30,000 | $240,900 |
| 2026-02-19 | Moran Kevin Patrick | SVP, CFO & Treasurer | 买入 | 125,000 | $0 |
| 2026-02-19 | Wijkstrom Joakim | SVP, Chief Marketing Officer | 买入 | 125,000 | $0 |
| 2026-02-19 | Birznieks Gunther | SVP, Business Development | 买入 | 125,000 | $0 |
| 2026-02-19 | Polymeropoulos Mihael Hristos | President and CEO | 买入 | 525,000 | $0 |
| 2026-02-19 | Williams Timothy | SVP & General Counsel | 买入 | 125,000 | $0 |
| 2025-08-08 | Polymeropoulos Mihael Hristos | President and CEO | 买入 | 10,000 | $41,500 |
| 2025-06-16 | Mitchell Stephen Ray | 董事 | 卖出 | 7,000 | $32,130 |
| 2025-06-09 | Chrousos Phaedra | 董事 | 买入 | 59,225 | $0 |
| 2025-06-09 | Ward Anne Sempowski | 董事 | 买入 | 59,225 | $0 |
| 2025-06-09 | Honore Tage | 董事 | 买入 | 59,225 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-08